Allelica, Inc’s Post

Through our efforts in IVPN - Personalized Medicine, we aim to bridge gaps in knowledge, foster collaboration, and empower underrepresented communities to participate in and benefit from advances in genomic medicine. This is more than just science—it's about transforming lives, improving health outcomes, and ensuring that no one is left behind in the genomic revolution. 🌍🔬 #GenomicMedicine #EquityInHealthcare #GlobalHealth #WHO #PrecisionMedicine

Systems medicine represents a paradigm shift in how we approach healthcare, integrating various layers of biological, clinical, and environmental data to create a more holistic and personalized approach to treatment. By synthesizing genomics, proteomics, metabolomics, and environmental data, systems medicine not only helps us understand the complex interplay of factors driving health and disease but also enables more precise interventions. This innovative approach goes beyond treating symptoms. It considers patients as dynamic systems, evolving over time and influenced by myriad factors. For example, in newborn genomic screening, systems medicine enables early identification of potential health risks, paving the way for timely and tailored preventive measures. Moreover, by embracing systems biology and data analytics, we can improve diagnostic accuracy, reduce trial-and-error prescribing, and enhance the prediction of disease progression. It’s an exciting time for those of us in genomic medicine as we explore the limitless potential of these data-driven insights in clinical settings. As healthcare shifts towards prevention and precision, systems medicine will be a critical foundation in achieving these goals, promising a future where treatment is not only reactive but predictive, personalized, and proactive. #SystemsMedicine #SystemsBiology #PrecisionHealth #HealthcareInnovation #PersonalizedMedicine #PreventiveMedicine #DataDrivenHealthcare

🧬 Breaking Ground in Precision Medicine: Leads the Genomic Revolution with Israel's Psifas Project. Proud to share the remarkable progress of Israel's National Genomic Database initiative - PSIFAS as featured tonight on Channel 12 News Israel: • 4% of volunteers receive potentially life-saving medical insights • Thousands of genomic sequences processed annually at Clalit's advanced sequencing center • Target: 100,000 samples to accelerate Israel's biotech industry "We joined this crucial national initiative from day one to provide our members with the most advanced medical care - proactive, preventive, and personalized," says Prof. Ran Balicer, Chief Innovation Officer at Clalit Health Services. Leading the future of personalized medicine! #PrecisionMedicine #HealthTech #IsraelInnovation #Healthcare #Genomics #Biotech #ClalitHealth

Korea has officially launched the National Bio Big Data Initiative, a project aimed at establishing a comprehensive bio big data platform to advance precision and personalized medicine. The launch ceremony, held on Thursday at the El Tower in Seoul, marked the start of a large-scale effort to collect and manage data from one million participants by 2032.

Today is a significant milestone as Kansai Medical University and Genesis Healthcare announce a collaborative research initiative, utilizing genomic big data and A.I. in Japan. We are excited to introduce the country's first joint research effort, combining the genomic big data from both institutions and leveraging artificial intelligence to accelerate new discoveries in psychiatric, immune, cardiovascular, and respiratory diseases. For additional information visit: https://lnkd.in/g65ufpAd #KMU #kansaimedicaluniveristy #genesishealthcare #genelife #genesisgaia #genesispro #genetics #biotech #techbio #genomics #genomicdata #Japan #asia #lifesciences #JapanBio #research #R&D #wgs #sequencing #bigdata #AI #genomicdata

The following Special Issue is now announced online at the Journal of Personalized Medicine MDPI. 💥Current Therapeutic Strategies and Future Perspectives for Infectious Diseases💥 🎓 Led by Dr. Duduzile Ndwandwe from South African Medical Research Council (SAMRC) 📌The articles in this issue will cover a range of #infectious diseases, including bacterial, viral, fungal, and parasitic infections. Key topics will address recent developments in #antimicrobial therapy, including novel drug discoveries, repurposing existing medications, and exploring alternative treatments such as bacteriophage therapies and immunotherapies. Additionally, contributions will investigate the integration of nanotechnology, gene editing, and personalized medicine to transform the management of infectious diseases. ➡For more information, please visit: https://lnkd.in/gXN4vRvt 📅 Submission Deadline: 25 October 2025 🙌We welcome your submissions!

𝐌𝐞𝐝𝐢𝐜𝐢𝐧𝐞: 𝐅𝐫𝐨𝐦 𝐌𝐚𝐜𝐫𝐨 𝐭𝐨 𝐌𝐢𝐜𝐫𝐨 – 𝐄𝐧𝐡𝐚𝐧𝐜𝐢𝐧𝐠 𝐏𝐚𝐭𝐢𝐞𝐧𝐭 𝐎𝐮𝐭𝐜𝐨𝐦𝐞𝐬 The evolution of healthcare from generalized treatments to personalized approaches has been accelerated by advances in omics sciences. As we shift from broad-spectrum treatments to precise, data-driven insights at the molecular level—through genomics, proteomics, metabolomics, and beyond—our understanding of each patient’s unique health profile deepens significantly. This movement from "macro" to "micro" is more than a shift in scale; it is a paradigm change that combines comprehensive molecular insights with each patient's clinical data. Genomics reveals genetic susceptibilities, proteomics provides a snapshot of protein interactions and biomarkers, while metabolomics sheds light on metabolic health and disease pathways. Together, these omics layers create a multidimensional view of health, allowing healthcare providers to detect early disease markers, pinpoint specific treatment targets, and deliver interventions that are finely tuned to each patient’s biological and clinical context. In practice, these advances make it possible to predict disease risks, design tailored treatment plans, and prevent illness with unprecedented accuracy. This synergy of molecular and clinical insights empowers providers to adopt proactive strategies that can slow disease progression or even prevent its onset. The result is more effective, efficient healthcare, with outcomes that extend beyond symptom management to long-term well-being and preventive care. #Omics #PrecisionMedicine #PatientOutcomes #PersonalizedHealthcare #ClinicalData #MolecularInsights #MolecularMedicine

🗣️ Our latest public attitudes for genomic policy brief is out now The National Precision Medicine Program in Singapore generates and integrates genomic, health, and environmental data of up to one million individuals to support research in healthcare innovation. This blog describes ongoing consultation of Singaporeans to gather input on with whom genomic data should be shared, under what conditions, and for what purpose.  Read more here: https://bit.ly/45RKxsc

Personalized Medicine in its true sense Docliv, based in Zurich, Switzerland, specializes in pharmacogenetic reviews for clinics, doctors, pharmacies, and patients. Using their own machine learning models, Docliv delivers some of the most accurate pharmacogenetic reviews available, empowering healthcare providers to make informed, personalized decisions. In Europe, genomic profiles are often created reactively - only after treatments fail or adverse effects occur. This reactive approach means that pharmacogenetic insights are applied too late, after patients have already suffered. In Qatar, however, initiatives like the Qatar Genome Programme (QGP) offer a unique opportunity to use pharmacogenetic reviews proactively - to identify the best medications from the start, avoiding trial-and-error treatments. Qatar is creating the potential to lead the way in precision health and personalized medicine. As founders of Docliv, Dr. Marco Egbring and I are excited to contribute to these visionary initiatives and collaborate with those who share our mission of advancing personalized healthcare for better outcomes. Let’s shape the future of personalized medicine together. #PrecisionMedicine #Pharmacogenetics #AI #Genomics #IntelligentHealth #PersonalizedMedicine

This is going to be a very useful course for people interested in #RCTs and research.